CO-Q10 Supplementation Improves Fatty Liver, Reduces Markers of Inflammation in NAFLD
A new randomized double blind trial of both men and women with NAFLD (Nonalcoholic fatty liver disease) found positive results for supplemental coenzyme Q10. NAFLD describes a disease of the liver that is characterized by fat accumulation in the liver, enlargement of the liver and increased serum liver enzyme levels. Increase inflammation also accompanies this…